Cyprus vs Qatar: Cause of death, by non-communicable diseases, ages 60+, female
Cyprus
84.5%
in 2021
Qatar
84.6%
in 2021
Cyprus rank
30th
Qatar rank
29th
Cause of death, by non-communicable diseases, ages 60+, female over time
- Cyprus
- Qatar
How they compare
Qatar currently reports 84.6% against 84.5% in Cyprus, a difference of 0.1%.
The two have swapped places 2 times across 6 shared years of data; in 2000 it was Qatar ahead.
Cyprus ranks 30th and Qatar ranks 29th of 185 countries.
Across the 3 decades both report, Cyprus averaged higher in 1 and Qatar in 2.
Head to head by decade
| Decade | Cyprus | Qatar | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 93.2% | 95.2% | 2.0% | Qatar |
| 2010s | 91.9% | 95.2% | 3.2% | Qatar |
| 2020s | 87.2% | 85.9% | 1.4% | Cyprus |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cause of death, by non-communicable diseases, ages 60+, female, Cyprus or Qatar?
- Qatar, at 84.6% against 84.5% in Cyprus as of 2021.
- What is the difference in cause of death, by non-communicable diseases, ages 60+, female between Cyprus and Qatar?
- 0.1%, with Qatar ahead.
- How many years of comparable data are there for Cyprus and Qatar?
- 6 years are reported by both, from 2000 to 2021.
- How do Cyprus and Qatar rank globally for cause of death, by non-communicable diseases, ages 60+, female?
- Cyprus ranks 30th and Qatar ranks 29th of 185 countries.
- Where does this data come from?
- Global Health Estimates, World Health Organization (WHO), published as Cause of death, by non-communicable diseases, ages 60+, female (% of total female deaths ages 60+). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of female deaths ages 60+ due to non-communicable diseases divided by number of all female deaths ages 60+, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.